BNP and NT-proBNP Market: Is 2026 the Year Cardiac Biomarkers Go...

Ajouter une nouvelle offre d'emploi Health

2026-01-23 09:05:20 -

BNP and NT-proBNP Market: Is 2026 the Year Cardiac Biomarkers Go "Universal" in Primary Care?

As of January 23, 2026, the BNP and NT-proBNP market is identifying as a cornerstone of the global cardiovascular diagnostics sector, with its 2026 valuation reaching approximately $1.57 billion to $2.4 billion. The 2026 landscape is defined by a strong CAGR of approximately 12.4% to 14.9%, as health systems worldwide pivot toward these peptides for early heart failure (HF) detection. This 2026...

0 Commentaires 0 Parts 567 Vue 0 Aperçu